FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you.
XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program
Categories Side Effects
Update : Strategies for managing pancreatic cancer pain
Most relevant for: People with pancreatic cancer who are dealing with related pain.
Abdominal pain is often a severe, ongoing symptom of pancreatic cancer, yet little research has been done on how to best reduce this pain. The authors of this review discuss current strategies for managing cancer-related pain and their effectiveness. (Posted 10/31/22)
Este artículo está disponible en español.
Read More
Relevance: High


Strength of Science: Medium-High


Research Timeline: Post Approval


Study : Acupuncture may ease breast cancer treatment side effects
Relevance: High


Strength of Science: Medium-High


Research Timeline: Post Approval


Most relevant for: People considering acupuncture for managing breast cancer treatment symptoms.
Acupuncture can ease some symptoms of breast cancer treatment. Multiple studies found that acupuncture is a safe and effective strategy to manage certain symptoms but also called for more rigorous research on the topic. (Posted 9/28/22) Este artículo está disponible en español.
Read More
Update : FDA reports on new cancers linked to breast implants
Most relevant for: People with breast implants
New cancers have been found in women with both textured and smooth implants that are filled with either saline or silicone. These cancers are extremely rare. The FDA has reported cases of a type of skin cancer and blood cancers in the scar tissue that forms around breast implants. The newly reported lymphomas are different from the previously reported breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). (Posted 9/27/22). Este artículo está disponible en español.
Read More
Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Human Research


Study : PARP inhibitor treatment for metastatic prostate cancer shows most benefit in men with inherited BRCA mutations
Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Human Research


Most relevant for: People with metastatic castration resistant prostate cancer who have an inherited or tumor mutation in BRCA2.
This study looked at the benefit of using the PARP inhibitor niraparib to treat metastatic castration-resistant prostate cancer (mCRPC). Participants included those with an inherited or tumor mutation in BRCA1 or BRCA2 or an inherited or tumor mutation in another gene that affects DNA repair. Participants with an inherited or tumor mutation in BRCA1 or BRCA2 had better survival compared to those without a BRCA mutation. Side effects from niraparib were common, and consistent with previous reports for PARP inhibitors. (posted 9/6/2022)
Este artículo está disponible en español.
Read More
Relevance: Medium-High


Strength of Science: High


Research Timeline: Post Approval


Study : Physical activity may decrease fatigue associated with cancer treatment
Relevance: Medium-High


Strength of Science: High


Research Timeline: Post Approval


Most relevant for: Cancer patients who are experiencing fatigue related to cancer or its treatment.
Many cancer survivors experience fatigue during and after they complete treatment. This study looked at the effect of home-based physical activity on fatigue in cancer survivors. It also looked at whether frequent counseling encouraged people to start and continue their exercise routines. (Posted 8/1/22). Este artículo está disponible en español.
Read More
Relevance: High


Strength of Science: Medium-High


Research Timeline: Post Approval


Study : The hidden financial burden of treating cancer care symptoms
Relevance: High


Strength of Science: Medium-High


Research Timeline: Post Approval


Most relevant for: People who are experiencing side effects due to cancer treatment or cancer.
Drugs commonly used to treat symptoms of cancer and cancer treatment side effects can cost thousands of dollars out of pocket for patients, depending on what drugs are used. (Posted 6/29/2022). Este artículo está disponible en español.
Read More
Relevance: Medium


Strength of Science: Medium-High


Research Timeline: Post Approval


Study : Increasing melatonin use raises concerns
Relevance: Medium


Strength of Science: Medium-High


Research Timeline: Post Approval


Most relevant for: people who take or consider taking melatonin to help with sleep.
Adult use of melatonin as a sleep aid has increased even though its benefits and risks are not well understood. This study looked at trends in melatonin use over the last 19 years. (Posted 4/14/2022)
Este artículo está disponible en español.
Read More
Relevance: Medium-High


Strength of Science: High


Research Timeline: Post Approval


Study : Quality of life for people with early-stage breast cancer who participated in the OlympiA clinical trial
Relevance: Medium-High


Strength of Science: High


Research Timeline: Post Approval


Most relevant for: People with inherited mutations in BRCA1 or BRCA2 who have been diagnosed with early-stage, HER2-negative breast cancer.
The OlympiA study showed that the PARP inhibitor olaparib (Lynparza) is effective when used as maintenance therapy for people with an inherited BRCA1 or BRCA2 mutation who have early-stage breast cancer. Patient-reported outcomes from OlympiA suggest that olaparib was well tolerated and did not reduce quality of life or delay recovery from chemotherapy. (posted 2/22/22) Update: Based on OlympiA results, the FDA approved olaparib as adjuvant treatment for people with an inherited BRCA mutation who were diagnosed with early-stage HER2-negative breast cancer at high risk for recurrence. (03/11/2022).
Este artículo está disponible en español.
Read More
Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Human Research


Study : Cannabis use among breast cancer patients
Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Human Research


Most relevant for: People interested in using cannabis to relieve treatment side effects.
This study looked at patterns of cannabis use among breast cancer patients who are members of online health communities. Almost half of the study participants reported using cannabis to help manage treatment symptoms and side effects. The study also looked at reasons why patients used cannabis, where they obtained it and whether they perceived cannabis to be safe. While this study only looked at cannabis use among breast cancer patients it is likely results would be similar among patients diagnosed with other types of cancers. (posted 1/25/22)
Este artículo está disponible en español.
Read More
Relevance: High


Strength of Science: Medium-High


Research Timeline: Post Approval


Study : Physical activity may prevent chemotherapy-related cognitive decline in women with breast cancer
Relevance: High


Strength of Science: Medium-High


Research Timeline: Post Approval


Most relevant for: People concerned about the impact of chemotherapy
Many people experience chemo brain or chemo fog (cognitive effects) during and after chemotherapy. Researchers looked at the impact of physical activity on chemotherapy-related decline in memory, attention and information processing in women with breast cancer. This study shows that more physical activity before and during chemotherapy is linked to better information processing after chemotherapy. (Posted 1/6/22)
Este artículo está disponible en español.
Read More